Диссертация (1174326), страница 26
Текст из файла (страница 26)
785–799.193. Signore C., Mills J.L., Qian C. Circulating angiogenic factors and placentalabruption // Obstet Gynecol. – 2006. – 108. - P. 338–344.194. Sikkema J.M., Franx A., Bruinse H.W., van der Wijk N.G., de Valk H.W., NikkelsP.G. Placental pathology in early onset pre-eclampsia and intra-uterine growth restrictionin women with and without thrombophilia // Placenta. - 2002.
- 23(4). – P. 337-42.195. Sircar M., Thadhani R., Karumanchi S.A. Pathogenesis of preeclampsia // Curr OpinNephrol Hypertens. – 2015. – 24. – P. 131–138.155196. Skrzypczak J., Jasiński P., Wirstlein P., Goździewicz T., Rajewski M. Histologicchanges in placenta and chorion of women with antiphospholipid syndrome and inheritedthrombophilia // Ginekol Pol. - 2011. – 82 (9).
– P. 652-663.197. SmithS.K., HeY., Clark D.E. Angiogenic growth factor expression in placenta //J.Semin. Perinatal. – 2000. – l. - P. 82-86.198. Sobel M.L., Kingdom J., Drewlo S. Angiogenic response of placental villi to heparin// Obstet Gynecol. – 2011. - 117(6). – P. 1375-1383.199. Song G.
G., Kim J. H., Lee Y. H. Associations between vascular endothelial growthfactor gene polymorphisms and pre-eclampsia susceptibility: a meta-analysis //Immunological investigations. – 2013. - 42(8). – P. 749-762.200. Staff A.C., Dechend R., Pijnenborg R. Learning from the placenta: acute atherosisand vascular remodeling in preeclampsia-novel aspects for atherosclerosis and futurecardiovascular health // Hypertension.
– 2010. - 56(6). – P. 1026–1034.201. Tersigni C., Marana R., Santamarìa A., Castellani R., Scambia G., Simone N.D. Invitro evidences of heparin's effects on embryo implantation and trophoblast development// Reprod Sci. – 2012. - 19(5).
– P. 454-462.202. Tjoa M.L., Oudejans C.B., van Vugt J.M. Markers for presymptomatic prediction ofpreeclampsia and intrauterine growth restriction // Hypertens Pregn. - 2004. – 23. – P.171–89.203. Toal M., Keating S., Machin G., Dodd J., Adamson S.L., Windrim R.C.Determinants of adverse perinatal outcome in high-risk women with abnormal uterineartery Doppler images // American Journal of Obstetrics and Gynecology. – 2008. 198(3). – P. 330.e1–330.e7.204. Todros T., Sciarrone A., Piccoli E., Guiot C., Kaufmann P.
Umbilical Dopplerwaveforms and placental villous angiogenesis in pregnancies complicated by fetal growthrestriction // Kingdom J Obstet Gynecol. – 1999. - 93 (4). – P. 499-503.205. Tsatsaris V., Goffin F., Munaut C. Overexpression of the soluble vascularendothelial growth factor receptor in preeclamptic patients: pathophysiologicalconsequences // J Clin Endocrinol Metab. – 2003. – 88. – P. 5555-5563.156206. Tse J.Y., Lao T.T., Chan C.C., Chiu P.M., Cheung A.N. Expression of vascularendothelial growth factor in third-trimester placentas is not increased in growth-restrictedfetuses // J Soc Gynecol Investig. – 2001.
– 8. – P. 77–82.207. van Rijn B.B., Hoeks L.B., Bots M.L., Franx A., Bruinse H.W. Outcomes ofsubsequent pregnancy after first pregnancy with early-onset preeclampsia // Am J ObstetGynecol. – 2006. - 195(3). – P. 723–728.208. Viero S., Chaddha V., Alkazaleh F., Simchen M., Malik A., Kelly E.
Prognosticvalue of placental ultrasound in pregnancies complicated by absent end-diastolic flowvelocity in the umbilical arteries // Placenta. – 2004. - 25(8-9). – P. 735–41.209. Vintzileos M., Ananth C.V. First trimester prediction of ischemic placental disease// Semin Perinatol. – 2014. – 38.
– P. 159–166.210. Walker M.G., Fitzgerald B., Keating S., Ray J.G., Windrim R., Kingdom J.C. Sexspecific basis of severe placental dysfunction leading to extreme preterm delivery //Placenta. – 2012. - 33(7). - 568–571.211. Wikstrom A.K., Stephansson O., Cnattingius S.
Previous preeclampsia and risks ofadverse outcomes in subsequent nonpreeclamptic pregnancies // Am J Obstet Gynecol. –2011. - 204(2). – P. 148e1–148e6.212. Wu, O., Robertson, L., Twaddle, S., Lowe, G., Clark, P., Walker, I., Brenkel, I.,Greaves, M., Langhorne, P., Regan, L. & Greer, I. Screening for thrombophilia in highrisk situations: a meta-analysis and cost–effectiveness analysis // British Journal ofHaematology.
– 2005. – 131. – P. 80–90.213. Yagel S. Angiogenesis in gestational vascular complications // Thromb Res. – 2011.-127. – P. 64-66.214. Yinon Y., Ben Meir E., Margolis L., Lipitz S., Schiff E., Mazaki-Tovi S., SimchenM.J. Low molecular weight heparin therapy during pregnancy is associated with elevatedcirculatory levels of placental growth factor // Placenta. - 2015. -36(2).
– P. 121-124.215. Zamudio S., Wheeler T., Anthony F.W., Moore LG. Vascular endothelial growthfactor (VEGF), vascular resistance and villous angiogenesis at high altitude (3100 m) // JSoc Gynecol Investig. – 2002. – 9. – P. 141-145..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
